Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitor

European Neuropsychopharmacology

Volumn 8, Issue 4, 1998, Pages 255-259

  Garcia de Mateos Verchere, J ^a   Vaugeois, J M ^a   Naudin, B ^a   Costentin, J ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

3H WIN 35428 in vivo binding; Dopamine uptake inhibition; Locomotor activity; Mouse; Oxolinic acid

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DEXAMPHETAMINE; HALOPERIDOL; OXOLINIC ACID; RESERPINE;

AKINESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SYNAPTOSOME;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; ANTI-INFECTIVE AGENTS; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; OXOLINIC ACID; RADIOLIGAND ASSAY; RATS; RESERPINE;

EID: 0032403710     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00083-7     Document Type: Article

References (17)

1. Arnt J. Hyperactivity induced by stimulation of separate dopamine D1 and D2 receptors in rats with bilateral 6-OHDA lesions. Life Sci. 37:1985;717-723.
2. Arnt J. Behavioural stimulation is induced by separate dopamine D1 and D2 receptor sites in reserpine-pretreated but not in normal rats. Eur. J. Pharmacol. 113:1985;79-88.
3. Bonnet J.-J., Chagraoui A., Protais P., Costentin J. Interactions of amineptine with the neuronal dopamine uptake system. Neurochemical in vitro and in vivo studies. J. Neural Transm. 69:1986;211-220.
4. Bonnet J.-J., Costentin J. GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo. Eur. J. Pharmacol. 121:1986;199-209.
5. Chermat R., Simon P. Insomnie imputable à l'acide oxolinique. Nouv. Presse Méd. 6:1977;3754.
6. Danion J.M., Imbs J.L., Zeis P., Singer L. Syndrome confuso-délirant imputable à l'acide oxolinique. Ann. Med. Psychol. 140:1982;351-352.
7. D'Angelo L., Monti J.M. Effects of oxolinic acid on the sleep-wakefulness cycle of the rat. Br. J. Pharmacol. 74:1981;399-404.
8. Duterte-Boucher D., Kamenka J.-M., Costentin J. Comparison of the effects of three indirect dopamine agonists, GK 13, GBR 12783 and dexamphetamine on behavioural tests involving central catecholaminergic transmissions. Psychopharmacology. 101:1990;344-353.
9. Giardina W.J. Assessment of temafloxacin neurotoxicity in rodents. Am. J. Med. 91:1991;42S-44S.
10. Iorio L.C., Barnett A., Leitz F.H., Houser V.P., Korduba C.A. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol. Exp. Ther. 226:1983;462-468.
11. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
12. Poncelet M., Chermat R., Soubrié P., Simon P. The progressive ratio schedule as a model for studying the psychomotor stimulant activity of drugs in the rat. Psychopharmacology. 80:1983;184-189.
13. Renwart N., Frances H., Simon P. The calcium entry blokers: antimanic drugs? Prog. NeuroPsychopharm. Biol. Psychiatry. 10:1986;717-722.
14. Thiébot M.H., Kloczko J., Chermat R., Simon P., Soubrié P. Oxolinic acid and diazepam their reciprocal antagonism in rodents. Psychopharmacology. 67:1980;91-95.
15. Vaugeois J.M., Bonnet J.J., Dutertre D., Costentin J. In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion. Eur. J. Pharmacol. 230:1993;195-201.
16. Westerink B.H., Damsma G., de Vries J.B., Koning H. Dopamine reuptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat. Eur. J. Pharmacol. 135:1987;123-128.
17. Yamada T., Nakamura J., Okuno Y., Hosokawa S., Matsuo M., Yamada H., Ohta M. A possible mechanism for the increase in serum luteinizing hormone levels in male rats by oxolinic acid. Toxicol. Appl. Pharmacol. 134:1995;35-42.